Records containing: Immune Thrombocytopenia

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2017-04-26
  Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics
• CLINICAL_TRIALS study record update · 2017-02-01
  A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013
• CLINICAL_TRIALS study record update · 2017-01-26
  A Multi-center Randomized Clinical Trial of Regulating Gut Microbiota by Probiotic Agents in Management of Immune Thrombocytopenia
• CLINICAL_TRIALS study record update · 2017-01-19
  A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP)
• CLINICAL_TRIALS study record update · 2017-01-06
  A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) With High Anti-platelet Antibodies Level
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2016-11-18
  A Multi-Center Prospective Blind Study of RP% Measurement by Flow Cytometry in the Diagnosis of Primary Immune Thrombocytopenia
• CLINICAL_TRIALS study record update · 2016-07-15
  Low-dose Rituximab in Combination With Eltrombopag and High-dose Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
• CLINICAL_TRIALS study record update · 2016-07-15
  A Multicenter Randomized Study of Dexamethasone Combined With Rituximab, Cyclosporin and Intravenous Immunoglobulin in the Management of Newly Diagnosed ITP Patients
• CLINICAL_TRIALS study record update · 2016-05-25
  Prospective, Non-Randomized, Open-label, Single-arm, Multi-Center Phase III Clinical Trial to Evaluate the Efficacy and Safety of IV-Globulin SN Inj.10% in the Patients Diagnosed With Immune Thrombocytopenia (ITP).
• CLINICAL_TRIALS study record update · 2016-05-17
  Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
• CLINICAL_TRIALS study record update · 2016-05-13
  Rituximab Plus Short-term Methylprednisolone Versus Standard Dose Methylprednisolone in Newly Diagnosed Participants With Immune Thrombocytopenia (ITP): A Multicenter, Randomized Phase II Study in China
• CLINICAL_TRIALS study record update · 2016-04-26
  Thrombocytopenia in Gestational Period
• CLINICAL_TRIALS study record update · 2016-04-20
  A Prospective, Multicenter Study on the Alteration of Different Immune Parameters in ITP Patients Receiving Eltrombopag Treatment.
• CLINICAL_TRIALS study record update · 2016-04-20
  Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）
• CLINICAL_TRIALS study record update · 2016-04-20
  Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP): a Prospective, Randomized Controlled Trial
• CLINICAL_TRIALS study record update · 2016-04-20
  A Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Different Doses of Dexamethasone for Management of Immune Thrombocytopenia (ITP)
• CLINICAL_TRIALS study record update · 2016-04-20
  A Study on the Alteration of Macrophage Function in the Spleen Tissue From Patients With Primary Immune Thrombocytopenia (ITP): a Multicenter, Perspective, Clinical Trial
• CLINICAL_TRIALS study record update · 2016-04-20
  A Multicentre Randomized Study of Caffeic Acid Tablets as a Second-line Therapy for the Treatment of Immune Thrombocytopenia (ITP)
• CLINICAL_TRIALS study record update · 2016-04-20
  2 Cycles Rituximab Compared With Standard Regimen in Management of ITP
• CLINICAL_TRIALS study record update · 2016-04-20
  An Open-label, Randomized Multicenter Investigation of High-dose Dexamethasone Combining Thalidomide Versus High-dose Dexamethasone Mono-therapy for Management of Newly-diagnosed Immune Thrombocytopenia
• CLINICAL_TRIALS study record update · 2016-04-20
  Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP)in Pregnancy: a Single-center Clinical Trial
• CLINICAL_TRIALS study record update · 2016-04-20
  A Randomized Study to Evaluate the Efficacy and Safety of Different Doses and Frequencies of Recombinant Human Thrombopoietin (rhTPO) in the Management of Primary Immune Thrombocytopenia (ITP)
• CLINICAL_TRIALS study record update · 2015-01-14
  An Observational Study to Evaluate the Efficacy of Romiplostim Administered at Every Other Week in Adult Patients With Chronic Immune Thrombocytopenia (ITP) Who Attained Platelet Counts ≥ 50 x 109/L After Weekly Doses of Romiplostim
• CLINICAL_TRIALS study record update · 2013-03-06
  A Multicenter, Single-Arm, Open Label Study Evaluating the Efficacy and Safety of Maintenance Treatment With Recombinant Human Thrombopoietin in Thrombocytopenic Subjects With Immune Thrombocytopenia
• CLINICAL_TRIALS study record update · 2013-01-09
  Evaluation of Oxidant Status in Patients With Immune Thrombocytopenia (ITP) and the Role of an Adjuvant Antioxidant Therapy